Primary Efficacy and Safety Results of a Phase 2, Double-Blind, Placebo-Controlled, Proof-of-Concept, Signal Detection Study of Pitolisant in Myotonic Dystrophy

Sleep Medicine 2026

View at publisher
Authors: D. Seiden, Johanna Hamel, Jean‐Denis Brisson, Hanns Lochmüller, A. Puwanant, Doris G. Leung, Laurie Gutmann, Ann Adee, Grant Runyan, George G. Nomikos
DOI: 10.1016/j.sleep.2025.107219
Cited by: 0

Fields of Study & Subjects

Sleep and related disorders Sleep and Wakefulness Research Genetic Neurodegenerative Diseases

Publication details

Journal / source
Sleep Medicine
Volume
138
Pages
107219–107219
Publication date
29 January 2026
Language
EN